Welcome to LookChem.com Sign In|Join Free
  • or
2-(benzyloxy)-9H-fluoren-9-one is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1369290-06-1

Post Buying Request

1369290-06-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1369290-06-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1369290-06-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,6,9,2,9 and 0 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1369290-06:
(9*1)+(8*3)+(7*6)+(6*9)+(5*2)+(4*9)+(3*0)+(2*0)+(1*6)=181
181 % 10 = 1
So 1369290-06-1 is a valid CAS Registry Number.

1369290-06-1Downstream Products

1369290-06-1Relevant academic research and scientific papers

Photoredox-Catalyzed Deoxygenative Intramolecular Acylation of Biarylcarboxylic Acids: Access to Fluorenones

Ruzi, Rehanguli,Zhang, Muliang,Ablajan, Keyume,Zhu, Chengjian

, p. 12834 - 12839 (2017)

An efficient deoxygenative radical cyclization reaction has been reported for the synthesis of fluorenones by employing various biarylcarboxylic acids via photoredox catalysis. Attractive features of this process include generation of acyl radical, which quickly underdone intramolecular radical cyclization. This method marks the first photocatalytic intramolecular acyl radical coupling for constructing carbon-carbon bond, which further synthesizes the valuable fluorenone products with mild conditions, good yields, and good functional-group compatibility.

CARBOXYLIC ACID COMPOUND

-

Page/Page column 21; 30, (2012/02/15)

[Problem] The present invention has an object to provide a compound having a GPR40 agonistic activity, which is useful as a pharmaceutical composition, an insulin secretion promoter, or an agent for preventing/treating diabetes. [Means for Solution] The present inventors have extensively studied a compound having a GPR40 agonistic activity, and as a result, they have found that the compound (I) of the present invention or a pharmaceutically acceptable salt thereof, in which a carboxylic acid is bonded to a bicyclic or tricyclic moiety through methylene, and further, a benzene ring substituted with a monocyclic 6-membered aromatic ring is bonded to a bicyclic or tricyclic moiety through —O-methylene or —NH-methylene, has an excellent GPR40 agonistic activity. They have also found that the compound has an excellent insulin secretion promoting action and strongly inhibits increase in the blood glucose after glucose loading, thereby completing the present invention.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1369290-06-1